Pawel Karpinski
Overview
Explore the profile of Pawel Karpinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mustfa S, Dimitrievska M, Wang C, Gu C, Sun N, Romanczuk K, et al.
Adv Mater
. 2025 Mar;
:e2414728.
PMID: 40072288
Base editing, a CRISPR-based genome editing technology, enables precise correction of single-nucleotide variants, promising resolutive treatment for monogenic genetic disorders like recessive dystrophic epidermolysis bullosa (RDEB). However, the application of...
2.
Myszka A, Ciesla M, Siekierzynska A, Sendera A, Constantinou C, Karpinski P, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768623
The majority of patients with bladder cancer suffer from tumour recurrence. Identifying prognostic factors for tumour recurrence is crucial for treatment and follow-up in affected patients. The study aimed to...
3.
Laczmanska I, Matkowski R, Supplitt S, Karpinski P, Abrahamowska M, Laczmanski L, et al.
Breast Cancer Res Treat
. 2024 Nov;
209(2):453.
PMID: 39579249
No abstract available.
4.
Karpinski P, Mendez-Pena J, Wu C, Akalin A, Cornejo K, Hung Y, et al.
Mod Pathol
. 2024 Sep;
38(1):100627.
PMID: 39341281
Although of therapeutic importance, a single sensitive and specific immunostain to distinguish Merkel cell carcinoma (MCC) from mimics is not currently available. In addition, single tumor cells are difficult to...
5.
Szmida E, Butkiewicz D, Karpinski P, Rutkowski T, Oczko-Wojciechowska M, Sasiadek M
Genes (Basel)
. 2024 Sep;
15(9).
PMID: 39336817
Background: Head and neck squamous cell carcinoma (HNSCC) is one of the most prevalent cancers worldwide. The identification of molecular alterations adding to the individual risk of HNSCC development and...
6.
Ozieblo S, Mizera J, Gorska A, Krzyzinski M, Karpinski P, Markiewicz A, et al.
Cells
. 2024 Aug;
13(16.
PMID: 39195238
Uveal melanoma (UM) is the most common primary intraocular tumor in adults, with no standardized treatment for advanced disease. Based on preliminary bioinformatical analyses DTYMK and PARP1 were selected as...
7.
Supplitt S, Karpinski P, Sasiadek M, Laczmanski L, Kujawa D, Matkowski R, et al.
J Appl Genet
. 2024 Aug;
66(1):249.
PMID: 39179763
No abstract available.
8.
Laczmanska I, Matkowski R, Supplitt S, Karpinski P, Abrahamowska M, Laczmanski L, et al.
Breast Cancer Res Treat
. 2024 Jul;
208(3):501-510.
PMID: 39080120
Introduction: Homologous recombination (HR) is a crucial DNA-repair mechanism, and its disruption can lead to the accumulation of mutations that initiate and promote cancer formation. The key HR genes, BRCA1...
9.
Szlasa W, Sauer N, Baczynska D, Zietek M, Haczkiewicz-Lesniak K, Karpinski P, et al.
Sci Rep
. 2024 May;
14(1):12546.
PMID: 38822068
Nanosecond pulsed electric field (nsPEF) has emerged as a promising approach for inducing cell death in melanoma, either as a standalone treatment or in combination with chemotherapeutics. However, to date,...
10.
Supplitt S, Karpinski P, Sasiadek M, Laczmanski L, Kujawa D, Matkowski R, et al.
J Appl Genet
. 2024 May;
66(1):171-182.
PMID: 38722458
Neoadjuvant chemotherapy is the foundation treatment for triple-negative breast cancer (TNBC) and frequently results in pathological complete response (pCR). However, there are large differences in clinical response and survival after...